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I. Introduction 
One of the major routes of metabolism of aromatic 
hydrocarbons involves the formation of dihydrodiols 
[ I] . These metabolites arise by the action of microsomal 
monooxygenases on the aromatic double bonds which 
forms epoxide intermediates [2,3] that are subsequently 
converted into dihydrodiols by microsomal ‘epoxide 
hydrase’ [4] or into glutathione conjugates by the 
soluble ‘glutathione S-epoxide transferase’ [5] . The 
dihydrodiols are themselves further metabolized by 
rat-liver preparations to intermediates that yield 
~utathione conjugates in the presence of the ‘trans- 
ferase [6]. This paper reports the synthesis of one 
such intermediate, 8,9-dihydro-8,9-d~ydroxybenz(a) 
anthracene IO,1 1 -oxide, and also presents evidence that 
this compound is formed from the benz(a)anthracene 
metabolite, 8,9-dihydro-8,9-dihydroxybenz(a)anthracene, 
by the microsornal fraction of rat-liver. The routes 
involved are summarized in scheme 1. 
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Scheme 1. Routes leading to the formation of 8,9-dihydro- 
8,9-dihydroxybenz(a)anthracene 10,l l-oxide. 
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2. Materials and methods 
2.1. Materials 
3 H-Labelled 8,9-dihydro8,9-dihydroxybenz(a) 
anthracene (sp. act. 150 mCi~mmole) and the u~abelled 
dihydrodiol were prepared enzymically from 3 H- 
labelled benz(a)anthracene and unlabelled benz(a) 
anthracene respectively [l] . 
In the preparation of 8,9-dihydro~,9-d~ydroxybe~ 
(a)anthracene 10,ll -oxide, the X,9-dihydrodiol(4 mg) 
and m -chloroperoxybenzoic acid (6 mg), in chloroform 
(3 ml), were kept at 0°C for 48 hr. The solution was 
washed once with 2 M NaOH (5 ml), three times with 
water (5 ml) and dried (Naz SOa) and the solvent 
removed under reduced pressure. The residue was 
chromatographed in system (b) (table l), the band 
containing the oxide removed and the product eluted 
with ethanol. The U.V. spectrum of the oxide, shown in 
fig. 1 (curve C), is similar to that of phenanthrene 
(fig. 1, curve D) and supports the proposed structure. 
The mass spectrum showed M, 278 (CrsHr403 
requires M, 278). The 3 H-labelled oxide was similarly 
prepared from the 3 H-labelled 8,9-dihydrodiol in 44% 
yield, as determined by radioacti~ty measurements. 
2.2. Liver preparations 
Microsomal and soluble cell fractions were prepared 
173 from the livers of male Chester Beatty strain rats 
that had been pre-treated with 3-methylcholanthrene 
111. 
2.3. Incubation of 3 H-labelled 8,9-dihydro-8,9-dihy- 
droxybenz(ajanthracene with microsomai fractions 
The reaction mixture (60 ml) contained microsomal 
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Thin-layer chromatography of 8,9-dihydro-8,9-dihydroxybenz(a)anthracene 10,l l-oxide and related compounds 
Compound RF X 100 in chromatographic 
system 
8,9-Dihydro-8,9-dihydroxybenz~a)anthracene 44 62 67 
8,9-Dihydro-8,9-dihydroxybenz(a)anthracene lO,ll-oxide (synthetic) 37 53 58 
8,9-Dihydro-8,9_dihydroxybenz(a)anthracene 10,l l-oxide (microsomal metabolite) 37 54 57 
Metabolite, probably 8,9,10,1 l-tetrahydro-8,9,10,11-tetrahydroxybenz(a)anthracene 14 10 12 
Chromatographic system (a), 0.25 mm layers of silica gel G developed with benzene:ethanol(87: 13 v/v); (b), Eastman 6060 
Chromogram sheets developed with cyclohexane:dioxan (1 :l v/v); (c) Eastman 6060 Chromogram sheets developed with ethyl 
acetate:n-hexane:acetic a id (15:4:1 by vol). 
fraction (E 10 g liver), NADP (18 mg), glucose 6- 
phosphate (90 mg), glucose 6-phosp~te dehydrogenase 
(42 units), cyclohexene oxide (60 E.tmoles in 0.6 ml 
ethanol) and 3 H-labelied 8,9-dihydro-8,9-dihydroxy 
benz(a)anthracene (3 @moles in 1.2 ml ethanol) in 
0.1 M pyrophosphate buffer (pH 8.0). The mixture 
was shaken at 37°C for 1 hr and extracted with 
diethyl ether (100 ml). The dried (Na:!SO*) extract 
was concentrated and examined by t.1.c. [system (b), 
table 1 ] . The major metabolite, which was visible as a 
dark absorbing area in U.V. light and was radioactive, 
was chromatographically identical with 8,9-dihydro- 
8,9_dihydroxybe~(a)anthracene lo,1 l-oxide. The 
metabolite, eluted from the appropriate areas of 
chromatograms with ethanol, was incubated with 0.1 
M phosphate buffer, pH 7.4 (9 ml), soluble fraction of 
rat-liver (1 ml) and GSH (3 mg) at 37°C for 1 hr. The 
mixture was extracted with ethyl acetate (15 ml) and 
the GSH conjugate in the aqueous phase examined by 
column chromatog~phy 181. 
3. Results and discussion 
Evidence that 8,9-dihydro8,9-dihydroxybenz(a) 
anthracene lo,1 1 -oxide is a microsomal metabolite of 
the 8,9-dihydrodiol is presented in table 1. When ether 
extracts, obtained from incubations of rat-liver 
microsomal fraction with the tritiated 8,9-dihydrodiol 
were examined by t.l.c., two radioactive products were 
Table 2 
Factors affecting the metabolism of 8,9dihydro-8,9-dihydroxybenz(a)anthracene 
by the microsomal fraction of rat-liver 
Modification to complete reaction mixture Radioactivity (cpm X 10-a) associated 
with metabolites 
10,l l-oxide 8,9,10,11-Tetrahydrotetrol 
Microsomal fraction heated* before incubation 0.5 0 
NADPH omitted 0.2 0 
Cyclohexene oxide omitted 18.6 14.3 
None 18.0 4.5 
* Heated at 100” for 5 min. 
Incubation conditions and the composition of the complete reaction mixture are described in the text. The 
mixtures (5 ml) were extracted with ether (IO ml) and the dried extract evaporated to dryness. The residues 
were dissolved in ethanol (60 ~1) and portions (10 ~1) of the solutions applied to Chromogram sheets 
(system fb), table 1). Appropriate areas of the chromatogram were cut out and the radioactivity present 
determined by liquid scintillation counting. 
31 
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Fig. 1. Ultra-violet absorption spectra measured in ethanol, 
of (A) 8,9~ihydro-8,9-dihydroxybenz(a~nth~cene; (B) 8,9- 
dihydro-8,9-dihydroxybenz(a)anthracene lo,1 l-oxide ob- 
tained from microsomal oxidations; (C) 8,9-dihydro-8,9- 
dibydroxybenz(a)anthracene lO,ll-oxide obtained by syn- 
thesis; (D) phenanthrene. The spectra of A, B and C were 
measured on samples purified by t.1.c. as described in the text. 
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located. The major, faster moving product exhibited 
the chromatographic properties of the synthetically- 
prepared 10,ll -oxide in three chromatographic 
systems. The more polar product is probably the 8,9, 
IO.11 -tetrahydrotetrol derivative formed by the further 
metabolism of the 10,ll -oxide, since epoxides are 
hydrated to dihydrodihydroxy derivatives by 
microsomal ‘epoxide hydrase’ [4] . This is supported by 
the finding that more of the polar metabolite is present 
in incubation mixtures that do not contain the ‘epoxide 
hydrase’ inhibitor, cyclohexene oxide [4] (table 2). 
Table 2 also demonstrates that microsom~ oxidation 
of the isolated IO,1 1 -bond of the 8,9-dihydrodiol is an 
enzymic reaction that requires NADPH. 
Confirmation of the structure of the microsomal 
nletabolite of the 8,9-dihydrodiol is provided by curves 
B and C in fig. 1, which shows that the metabolite and 
the synthetically prepared 8,9-dihydro-8,9-dihydroxy- 
benz(a)anthracene lo,11 -oxide exhibit similar U.V. 
absorption spectra that differ from that of the parent 
8,9-dihydrodiol (curve A). 
Furthermore, the microsomal metabolite reacted 
with GSH in the presence of the soluble cell fraction to 
form a GSH conjugate. The elution profile obtained 
with this conjugate, using a column chromatography 
system designed to separate GSH conjugates [8] , was 
identical to that obtained with a similar conjugate 
prepared enzymically from synthetic 8,9-d~ydro~,9- 
dihydroxybenz(a)anthracene IO,1 l-oxide and 
glutathione (G. R. Keysell, J. Booth and P. Sims, un- 
published observations) and the U.V. absorption 
spectra of the two conjugates were identical. 
The results show, therefore, that 8,9-dihydro-8,9- 
dihydroxybenz(a)anthracene, which is a metabolite of 
benz(a)anthracene in rats, rabbits and mice [9], in rat 
liver and lung preparations [lo] , and in hamster 
embryo cells [ 111 and human lymphocytes [I 2] , is 
itself further metabolized to an epoxide. The reactions 
of this diol-epoxide with DNA are described in the 
following paper [I 3 ] . 
Acknowledgements 
We thank Dr M. Jarman for the mass spectrum. This 
investigation was supported by grants to the Chester 
Beatty Research Institute (Institute of Cancer Research: 
Royal Cancer Hospital) from the Medical Research 
Council and the Cancer Research Campaign. 
Volume 47, number 1 FEBS LETTERS October 1974 
References 
(11 Sims, P. (1970) Biochem. Pharmacol. 19,795-818. 
[2] Grover, P. L., Hewer, A. and Sims, P. (1971) FEBS 
Letters 18, 76-80. 
[3] Selkirk, J. K., Huberman, E. and Heidelberger, C. (1971) 
Biochem. Biophys. Res. Commun. 43, 1010-1016. 
[4] Oesch, F. (1973) Xenobiotica, 3,305-340. 
[S] Boyland, E. and Will~ms, K. (1965) Biochem. J. 94, 
190-197. 
[6] Booth, J., Keysell, G. R. and Sims, P. (1973) Biochem. 
Pharmacol. 22,1781-1791. 
[7] Booth, J., Keysell, G. R. and Sims, P. (1974) Biochem. 
Pharmacol. 23,735-744. 
[8] Kuss, E. 11971) Hoppe-Seyler’s Z. Physic& Chem. 352, 
817-836. 
[9] Boyland, E. and Sims, P. (1964) Biochem. J. 91, 
493-506. 
[lo] Grover, P. L., Hewer, A. and Sims, P. (1974) Biochem. 
Pharmacol. 23, 323-332. 
[ 111 Sims, P., Grover, P. L., Kuroki, T., Huberman, E., 
Marquardt, H., Selkirk, J. K. and Heidelberger, C. (1973) 
Biochem. Pharmaco~. 22, l-8. 
[ 121 Booth, J., Keysell, G. R., Pal, K. and Sims, P. (1974) 
FEBS Letters 43, 341-344. 
[13] Swaisland, A. J., Hewer, A., Pal, K., Keysell, G. R., 
Booth, J., Grover, P. L. and Sims, P. (1974) FEBS Letters 
(accompanying paper). 
33 
